Literature DB >> 23208385

Evaluation of skin permeation of β-blockers for topical drug delivery.

Doungdaw Chantasart1, Jinsong Hao, S Kevin Li.   

Abstract

PURPOSE: β-Blockers have recently become the main form of treatment of infantile hemangiomas. Due to the potential systemic adverse effects of β-blockers, topical skin treatment of the drugs is preferred. However, the effect and mechanism of dosage form pH upon skin permeation of these weak bases is not well understood. To develop an effective topical skin delivery system for the β-blockers, the present study evaluated skin permeation of β-blockers propranolol, betaxolol, timolol, and atenolol.
METHODS: Experiments were performed in side-by-side diffusion cells with human epidermal membrane (HEM) in vitro to determine the effect of donor solution pH upon the permeation of the β-blockers across HEM.
RESULTS: The apparent permeability coefficients of HEM for the β-blockers increased with their lipophilicity, suggesting the HEM lipoidal pathway as the main permeation mechanism of the β-blockers. The pH in the donor solution was a major factor influencing HEM permeation for the β-blockers with a 2- to 4-fold increase in the permeability coefficient per pH unit increase. This permeability versus pH relationship was found to deviate from theoretical predictions, possibly due to the effective stratum corneum pH being different from the pH in the donor solution.
CONCLUSIONS: The present results suggest the possibility of topical treatment of hemangioma using β-blockers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23208385      PMCID: PMC3825625          DOI: 10.1007/s11095-012-0928-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  45 in total

1.  Predicting skin permeability.

Authors:  R O Potts; R H Guy
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

2.  Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

Review 3.  Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.

Authors:  W H Frishman; M S Fuksbrumer; M Tannenbaum
Journal:  J Clin Pharmacol       Date:  1994-08       Impact factor: 3.126

4.  Percutaneous penetration of N-nitrosodiethanolamine through human skin (in vitro): comparison of finite and infinite dose applications from cosmetic vehicles.

Authors:  T J Franz; P A Lehman; S F Franz; H North-Root; J L Demetrulias; C K Kelling; S J Moloney; S D Gettings
Journal:  Fundam Appl Toxicol       Date:  1993-08

Review 5.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

6.  The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane.

Authors:  K D Peck; A H Ghanem; W I Higuchi
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

7.  The ionization behavior of bile acids in different aqueous environments.

Authors:  D J Cabral; J A Hamilton; D M Small
Journal:  J Lipid Res       Date:  1986-03       Impact factor: 5.922

8.  cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation.

Authors:  G D'Angelo; H Lee; R I Weiner
Journal:  J Cell Biochem       Date:  1997-12-01       Impact factor: 4.429

9.  Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

10.  Effects of side chain length on ionization behavior and transbilayer transport of unconjugated dihydroxy bile acids: a comparison of nor-chenodeoxycholic acid and chenodeoxycholic acid.

Authors:  J Ko; J A Hamilton; H T Ton-Nu; C D Schteingart; A F Hofmann; D M Small
Journal:  J Lipid Res       Date:  1994-05       Impact factor: 5.922

View more
  5 in total

Review 1.  Educational paper: therapy of infantile haemangioma--history and current state (part II).

Authors:  Sherief R Janmohamed; Gerard C Madern; Peter C J de Laat; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2014-09-03       Impact factor: 3.183

2.  Methylation and Esterification of Magnolol for Ameliorating Cutaneous Targeting and Therapeutic Index by Topical Application.

Authors:  Chwan-Fwu Lin; Chi-Feng Hung; Ibrahim A Aljuffali; Yu-Ling Huang; Wei-Chun Liao; Jia-You Fang
Journal:  Pharm Res       Date:  2016-05-27       Impact factor: 4.200

3.  Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers.

Authors:  Jillian G Baker; Christophe Fromont; Marjorie Bruder; Kevin S J Thompson; Barrie Kellam; Stephen J Hill; Sheila M Gardiner; Peter M Fischer
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-01

4.  Topical treatment with propranolol gel as a supplement to the existing treatment of hemangiomas.

Authors:  Markus Schneider; Andreas Reimer; Hansjoerg Cremer; Peter Ruef
Journal:  World J Pediatr       Date:  2014-12-17       Impact factor: 2.764

5.  The Influence of Formulation and Excipients on Propranolol Skin Permeation and Retention.

Authors:  Cristina Padula; Sara Nicoli; Silvia Pescina; Patrizia Santi
Journal:  Biomed Res Int       Date:  2018-08-02       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.